SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI
Signals
- Driftsunderskudd 2025 Siste driftsresultat er negativt (−5,4 mill kr).
SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI is registered as a foundation in Oslo, Oslo with organisation number 979728123. The business is classified under activities of charities which distribute means themselves (NACE 94.991). The company was incorporated in 1990. Registered share capital is NOK 10.0m. The most recent filed accounts, for the 2025 financial year, show NOK 2.5m in revenue and NOK −5.4m in operating profit.
Former names: SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING
Key figures · 2025
Financial health · 2025
Who owns SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI?
No shareholders are registered for SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI in open Norwegian sources. Shareholder data exists mainly for limited companies (AS/ASA).
Which companies does SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI own?
SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI holds stakes in 8 companies:
- VECTRON BIOSOLUTIONS AS 2.8%
- GYLDENDAL ASA 1.4%
- ARENDALS FOSSEKOMPANI ASA 1.2%
- PHOTOCURE ASA 0.2%
- KONGSBERG GRUPPEN ASA 0.1%
- PCI BIOTECH HOLDING ASA 0.1%
- TEKNA HOLDING ASA 0.1%
- ELKEM ASA 0.1%
Frequently asked questions about SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI
What is the revenue of SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI?
SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI had revenue of NOK 2.5m in 2025.
Who is the general manager of SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI?
Hans Peter Bøhn is registered as general manager of SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI.
Where is SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI based?
SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI has its business address in Oslo.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 02.09.2026.